Zhitong Finance App learned that the decline in innovative drug concept stocks increased in the afternoon. As of press release, Goli Pharmaceutical-B (01672) fell 9.82% to HK$7.62; Nuocheng Jianhua (09969) fell 6.37% to HK$12.65; Sansheng Pharmaceuticals (01530) fell 4.20% to HK$15.04; and Cinda Biotech (01801) fell 3.90% to HK$93.7.

According to the news, the suspected plague virus infection incident in Russia's Irkutsk region recently attracted international attention. WHO spokesman Lindmeier said on October 6 that according to the information currently available, the WHO preliminary risk assessment concluded that the risk in the Irkutsk region was “moderate to low”, the overall risk in the Russian Federation was “low”, and the risk in the WHO European region was “very low.”

It is worth noting that due to the market's expectations of US inflation and the Federal Reserve's interest rate hike, the yield on US 30-year Treasury bonds recently fluctuated and rose to 5.72% intraday on October 7, which is about the highest level since 2002. Innovative drugs are typical “long-term assets”, and their value comes from distant future cash flows, so their valuations are highly sensitive to discount rates (interest rates).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.